Safety analysis of intermittent hemodialysis in patients with continuous flow left ventricular assist devices

Hemodialysis International

Volumn 18, Issue 1, 2014, Pages 205-209

  Quader, Mohammed A ^a   Kumar, Dhiren ^a   Shah, Keyur B ^a   Fatani, Yahya I ^a   Katlaps, Gundars ^a   Kasirajan, Vigneshwar ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Adverse events; Dialysis termination; Hemodialysis; LVAD

Indexed keywords

PHOSPHORUS;

ABDOMINAL CRAMP; ADULT; ARTICLE; ARTIFICIAL KIDNEY; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; DEVICE SAFETY; DOPPLER DEVICE; EQUIPMENT FAILURE; FEMALE; HEART VENTRICLE TACHYCARDIA; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPOTENSION; KIDNEY FUNCTION; LEFT VENTRICULAR ASSIST DEVICE; MALE; MIDDLE AGED; PATIENT SAFETY; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE PERIOD; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; YOUNG ADULT;

ADVERSE EVENTS; DIALYSIS TERMINATION; HEMODIALYSIS; LVAD;

ADULT; AGED; BLOOD FLOW VELOCITY; BLOOD PRESSURE; FEMALE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; SAFETY;

EID: 84891902497     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12073     Document Type: Article

References (13)

1. Kirklin JK, Naftel DC, Kormos RL, etal. The fourth intermacs annual report: 4, 000 implants and counting. J Heart Lung Transplant. 2012; 31:117-126.
2. Patel UD, Hernandez AF, Liang L, etal. Quality of care and outcomes among patients with heart failure and chronic kidney disease: A get with the guidelines-Heart Failure Program study. Am Heart J. 2008; 156:674-681.
3. Sandner SE, Zimpfer D, Zrunek P, etal. Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg. 2009; 87:1072-1078.
4. Butler J, Geisberg C, Howser R, etal. Relationship between renal function and left ventricular assist device use. Ann Thorac Surg. 2006; 81:1745-1751.
5. Myers TJ, Bolmers M, Gregoric ID, Kar B, Frazier OH. Assessment of arterial blood pressure during support with an axial flow left ventricular assist device. J Heart Lung Transplant. 2009; 28:423-427.
6. Orofino L, Marcen R, Quereda C, etal. Epidemiology of symptomatic hypotension in hemodialysis: Is cool dialysate beneficial for all patients. Am J Nephrol. 1990; 10:177-180.
7. Santoro A, Mancini E, Basile C, etal. Blood volume controlled hemodialysis in hypotension-prone patients: A randomized, multicenter controlled trial. Kidney Int. 2002; 62:1034-1045.
8. Slaughter MS, Pagani FD, Rogers JG, etal. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010; 29(4 Suppl):S1-39.
9. Hou SH, Zhao J, Ellman CF, etal. Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate. Am J Kidney Dis. 1991; 18:217-224.
10. Bender JS, Ratner LE, Magnuson TH, Zenilman ME. Acute abdomen in the hemodialysis patient population. Surgery. 1995; 117:494-497.
11. Andersen M, Videbaek R, Boesgaard S, Sander K, Hansen PB, Gustafsson F. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant. 2009; 28:733-735.
12. Misra M. The basics of hemodialysis equipment. Hemodial Int. 2005; 9:30-36.
13. Rose EA, Gelijns AC, Moskowitz AJ, etal. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001; 345:1435-1443.